Filters

Anti-CXCL2 siRNA

Anti-CXCL2 siRNA size: 15 nmol 528

Supplier ABBEX
Price 528
Size 15 nmol
CategorysiRNA
TargetCXCL2
ImmunogenSee techfile
Raised inSynthetic
Reactivity Mouse, Rat, Human
PurificationAffinity purified
ApplicationsWB (for other see techfile or inquire)
Stock availabilityShipped within 5-10 working days
Storage conditions Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C
WarningsThis product is for research use only
Gene targetCXCL2 siRNA
Short nameAnti-CXCL2 siRNA
Alternative nameantibody to-chemokine (C-X-C motif) ligand 2 small interfearing RNA
Alternative to gene target CINC-2a and GRO2 and GROb and MGSA-b and MIP-2a and MIP2 and MIP2A and SCYB2, CXCL2 and IDBG-24257 and ENSG00000081041 and 2920, Extracellular, chemokine activity, this GO :0002237 and response to molecule of bacterial origin and biological process this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0006935 and chemotaxis and biological process this GO :0006954 and inflammatory response and biological process this GO :0006955 and immune response and biological process this GO :0008009 and chemokine activity and molecular function this GO :0045087 and innate immune response and biological process this GO :0060326 and cell chemotaxis and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding and also this GO :0008009: chemokine activity, this GO :0008009: chemokine activity, chemokine (C-X-C motif) ligand 2
Identity 4603
Gene CXCL2
Long gene name C-X-C motif chemokine ligand 2
Synonyms gene GRO2
Synonyms gene name GRO2 oncogene chemokine (C-X-C motif) ligand 2
Synonyms SCYB2 GROb MIP-2a MGSA-b CINC-2a
Locus 4q13, 3
Discovery year 1991-05-21
GenBank acession M36820
Entrez gene record 2920
Pubmed identfication 2217207
RefSeq identity NM_002089
Classification Endogenous ligands Chemokine ligands
Havana BLAST/BLAT OTTHUMG00000160865

Subscribe to our Newsletter